Dasatinib in high-risk core binding factor acute myeloid leukemia in first complete remission: a French Acute Myeloid Leukemia Intergroup trial

Core-binding factor acute myeloid leukemia is a favorable acute myeloid leukemia subset cytogenetically defined by t(8;21) or inv(16)/t(16;16) rearrangements, disrupting RUNX1 (previously CBFA/AML1) or CBFB transcription factor functions. The receptor tyrosine kinase KIT is expressed in the vast maj...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Haematologica
Main Authors: Boissel, Nicolas, Renneville, Aline, Leguay, Thibaut, Lefebvre, Pascale Cornillet, Recher, Christian, Lecerf, Thibaud, Delabesse, Eric, Berthon, Céline, Blanchet, Odile, Prebet, Thomas, Pautas, Cécile, Chevallier, Patrice, Leprêtre, Stéphane, Girault, Stéphane, Bonmati, Caroline, Guièze, Romain, Himberlin, Chantal, Randriamalala, Edouard, Preudhomme, Claude, Jourdan, Eric, Dombret, Hervé, Ifrah, Norbert
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2015
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4450623/
https://ncbi.nlm.nih.gov/pubmed/25715404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.114884
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados